Stammdaten
United Therapeutics Corporation ist ein Biotechnologieunternehmen, das sich mit der Entwicklung und Vermarktung von Produkten zur Erfüllung ungedeckter medizinischer Bedürfnisse von Patienten mit chronischen und lebensbedrohlichen Erkrankungen in den Vereinigten Staaten und international befasst. Seine Handelstherapien umfassen Remodulin zur Behandlung von Patienten mit pulmonaler arterieller Hypertension (PAH) zur Verminderung mit Anstrengung verbundener Symptome; Tyvaso, eine inhalative Formulierung des Prostazyklin-Analogons Treprostinil zur Verbesserung der Trainingsleistung bei PAH-Patienten und pulmonaler Hypertension in Verbindung mit interstitieller Lungenerkrankung (PH-ILD); Orenitram, eine Tablettenform von Treprostinil zur Verbesserung der Trainingskapazität bei PAH-Patienten; Unituxin, ein monoklonaler Antikörper zur Behandlung von hochrisiko-Neuroblastom; und Adcirca, ein oraler PDE-5-Hemmer zur Verbesserung der Trainingsleistung bei PAH-Patienten. Das Unternehmen entwickelt auch Tyvaso DPI, eine Trockenpulver-Inhalationsform von Tyvaso; Remunity Pump, eine kleine, leichte, langlebige Pumpe und separaten Controller; RemoPro und Ralinepag zur Behandlung von PAH; Aurora-GT, ein Gen-Therapie-Produkt zum Wiederaufbau der Blutgefäße in den Lungen; und Tyvaso PERFECT und TETON-Studien, bei denen es sich um Studien von Tyvaso bei Patienten mit Weltgesundheitsorganisation (WHO) Gruppe 3 pulmonaler Hypertension in Verbindung mit chronisch obstruktiver Lungenerkrankung (PH-COPD) handelt. Das Unternehmen hat Lizenz- und Kooperationsvereinbarungen mit DEKA Research & Development Corp. zur Entwicklung eines teilweise verwendbaren Systems für die subkutane Abgabe von Treprostinil; MannKind Corporation zur Entwicklung und Lizenzierung von Treprostinil-Inhalationspulver und dem Dreamboat-Gerät; und Arena Pharmaceuticals, Inc. zur Entwicklung von Ralinepag. Das Unternehmen wurde 1996 gegründet und hat seinen Hauptsitz in Silver Spring, Maryland. KI
Unternehmen & Branche
| Name | UNITED THERAPEUTICS Corp |
|---|---|
| Ticker | UTHR |
| CIK | 0001082554 |
| Börse | Nasdaq |
| Sektor | Gesundheit |
| Industrie | Pharmazeutische Erzeugnisse |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 91307C102 |
|---|---|
| ISIN | US91307C1027 |
| Typ | Common Stock |
| Marktkapitalisierung | 23,06 Mrd. USD |
| KGV (P/E) | 18,97 |
| Beta | 0,58 |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 1000 SPRING ST, 20910 SILVER SPRING, MD |
| Telefon | 3016089292 |
| EIN (IRS) | 52-1984749 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Large accelerated filer |
Bewertung
| KBV (P/B) | 3,25 vs. 2,46 (2021) ▲ |
|---|---|
| KUV (P/S) | 7,25 vs. 5,78 (2021) ▲ |
| FCF-Rendite | 4,5 % vs. 4,9 % (2021) ▼ |
| Buyback-Rendite | 4,3 % |
Qualität & Bilanz
| Bruttomarge | 87,9 % vs. 92,7 % (2021) ▼ |
|---|---|
| Operative Marge | 46,9 % vs. 33,0 % (2021) ▲ |
| Nettomarge | 41,9 % vs. 28,2 % (2021) ▲ |
| ROIC | 18,8 % vs. 12,0 % (2021) ▲ |
| Zinsdeckungsgrad | 76,5 vs. 29,9 (2021) ▲ |
| Forderungslaufzeit (DSO) | 40 T vs. 43 T (2021) ▼ |
| Lagerreichweite (DIO) | 174 T vs. 279 T (2021) ▼ |
| Verbindlichkeitslaufzeit (DPO) | 7 T vs. 11 T (2021) ▼ |
| Cash-Conversion-Cycle (CCC) | 207 T vs. 311 T (2021) ▼ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 2,46 | 2,67 | 1,73 | 2,45 | 3,00 | 3,91 | |
| KUV (P/S) | 5,78 | 6,61 | 4,44 | 5,50 | 6,68 | 7,28 | |
| FCF-Rendite | 4,9 % | 5,2 % | 7,2 % | 6,8 % | 4,9 % | 4,4 % | |
| Buyback-Rendite | – | 0,0 % | 0,0 % | 6,3 % | 4,7 % | 10,8 % | |
| Qualität & Bilanz | |||||||
| Bruttomarge | 92,7 % | 92,2 % | 88,9 % | 89,2 % | 87,9 % | 86,6 % | |
| Operative Marge | 33,0 % | 50,6 % | 50,9 % | 47,9 % | 46,9 % | 45,3 % | |
| Nettomarge | 28,2 % | 37,6 % | 42,3 % | 41,5 % | 41,9 % | 40,6 % | |
| ROIC | 12,0 % | 15,2 % | 16,5 % | 18,5 % | 18,8 % | 21,8 % | |
| Zinsdeckungsgrad | 29,9 | 30,2 | 20,0 | 32,1 | 76,5 | 87,5 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
Score-Verlauf (90 Tage)
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 548.11 | -3.7 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 512.81 | +3.0 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 536.85 | EMA50: 544.16 | |
| MACD-Histogramm | Bärisch | 10 % | -0.796 | Bearisch | |
| RSI(14) | Neutral | 10 % | 41.9 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 20.2 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 18.7 | +DI: 14.1 / −DI: 19.6 | |
| Z-Score(60) | Bullisch | 5 % | -1.51 | Extrem überverkauft | |
| 52W-Position | Neutral | 5 % | 78.6 % | Hoch 596.76 / Tief 274.70 | |
| Bollinger(20,2σ) | Neutral | 5 % | 23.7 % | Upper 561.68 / Mid 539.58 / Lower 517.47 | |
| LinReg-Slope(60) | Bärisch | 10 % | -0.8098 | R²=0.73 / annualisiert -36.9 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-07-28 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -40 | 532,49 | -21.299,58 | -3,7% | |
| 2026-07-28 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.367 | 523,15 | -715.152,06 | -123,4% | |
| 2026-07-28 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.149 | 528,20 | -606.904,56 | -104,7% | |
| 2026-07-28 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.124 | 530,29 | -596.047,98 | -102,9% | |
| 2026-07-28 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.074 | 524,04 | -562.817,56 | -97,1% | |
| 2026-07-28 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -876 | 525,02 | -459.918,05 | -79,4% | |
| 2026-07-28 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -625 | 529,41 | -330.882,38 | -57,1% | |
| 2026-07-28 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -403 | 530,97 | -213.981,03 | -36,9% | |
| 2026-07-28 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.473 | 526,34 | -775.294,70 | -133,8% | |
| 2026-07-28 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.369 | 527,16 | -721.677,66 | -124,5% | |
| 2026-07-27 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -680 | 525,81 | -357.551,55 | -61,7% | |
| 2026-07-27 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -890 | 527,14 | -469.152,46 | -81,0% | |
| 2026-07-27 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -957 | 533,53 | -510.589,55 | -88,1% | |
| 2026-07-27 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.121 | 530,49 | -594.674,92 | -102,6% | |
| 2026-07-27 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.529 | 532,38 | -814.004,43 | -140,5% | |
| 2026-07-27 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.797 | 529,75 | -951.959,49 | -164,3% | |
| 2026-07-27 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.836 | 531,65 | -976.107,20 | -168,4% | |
| 2026-07-27 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -650 | 528,51 | -343.529,55 | -59,3% | |
| 2026-07-27 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -40 | 535,04 | -21.401,60 | -3,7% | |
| 2026-07-24 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -820 | 528,72 | -433.548,76 | -74,8% | |
| 2026-07-24 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -630 | 534,39 | -336.668,09 | -58,1% | |
| 2026-07-24 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.115 | 531,10 | -592.178,84 | -102,2% | |
| 2026-07-24 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -113 | 535,03 | -60.457,89 | -10,4% | |
| 2026-07-24 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.818 | 533,20 | -969.355,96 | -167,3% | |
| 2026-07-24 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.719 | 532,27 | -1.447.229,35 | -249,7% | |
| 2026-07-24 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.285 | 530,45 | -1.212.079,62 | -209,2% | |
| 2026-07-23 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.133 | 529,08 | -1.128.524,65 | -194,7% | |
| 2026-07-23 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -249 | 522,87 | -130.194,85 | -22,5% | |
| 2026-07-23 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -339 | 523,72 | -177.539,72 | -30,6% | |
| 2026-07-23 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -387 | 525,83 | -203.496,79 | -35,1% | |
| 2026-07-23 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.279 | 529,86 | -1.207.540,00 | -208,4% | |
| 2026-07-23 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.989 | 527,77 | -1.049.729,96 | -181,1% | |
| 2026-07-23 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.201 | 530,84 | -637.540,16 | -110,0% | |
| 2026-07-23 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -552 | 526,88 | -290.835,39 | -50,2% | |
| 2026-07-23 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -171 | 524,86 | -89.751,18 | -15,5% | |
| 2026-07-23 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -200 | 531,83 | -106.366,80 | -18,4% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -760 | 529,80 | -402.644,50 | -69,5% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -790 | 536,49 | -423.826,63 | -73,1% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -874 | 528,91 | -462.264,89 | -79,8% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.211 | 527,82 | -639.188,81 | -110,3% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.610 | 526,84 | -1.375.057,88 | -237,3% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -80 | 539,47 | -43.157,60 | -7,4% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -570 | 537,60 | -306.433,94 | -52,9% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -489 | 533,24 | -260.755,53 | -45,0% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -485 | 526,04 | -255.130,95 | -44,0% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -400 | 531,22 | -212.489,80 | -36,7% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -324 | 534,19 | -173.075,94 | -29,9% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -120 | 524,27 | -62.912,40 | -10,9% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -107 | 535,40 | -57.288,07 | -9,9% | |
| 2026-07-22 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -680 | 538,46 | -366.153,00 | -63,2% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.926 | 530,50 | -1.021.743,00 | -176,3% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.605 | 531,52 | -1.384.597,62 | -238,9% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -120 | 524,37 | -62.923,97 | -10,9% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -160 | 526,24 | -84.198,00 | -14,5% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -240 | 527,46 | -126.590,40 | -21,8% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -341 | 535,44 | -182.585,72 | -31,5% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -360 | 532,47 | -191.688,41 | -33,1% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -509 | 529,55 | -269.541,31 | -46,5% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -640 | 533,58 | -341.489,79 | -58,9% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -839 | 536,37 | -450.017,95 | -77,7% | |
| 2026-07-21 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.760 | 534,61 | -940.922,05 | -162,4% | |
| 2026-07-20 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -80 | 536,41 | -42.912,80 | -7,4% | |
| 2026-07-20 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -520 | 535,20 | -278.306,29 | -48,0% | |
| 2026-07-20 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -889 | 534,13 | -474.838,37 | -81,9% | |
| 2026-07-20 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -960 | 529,85 | -508.656,86 | -87,8% | |
| 2026-07-20 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.660 | 531,08 | -881.587,99 | -152,1% | |
| 2026-07-20 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.686 | 533,03 | -898.683,18 | -155,1% | |
| 2026-07-20 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.831 | 529,19 | -968.944,51 | -167,2% | |
| 2026-07-20 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.874 | 532,07 | -997.104,61 | -172,1% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -251 | 540,69 | -135.713,82 | -23,4% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -423 | 538,70 | -227.871,20 | -39,3% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -720 | 534,57 | -384.889,03 | -66,4% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -821 | 539,63 | -443.033,44 | -76,4% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -892 | 542,06 | -483.520,55 | -83,4% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.160 | 537,45 | -623.438,06 | -107,6% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.110 | 536,36 | -1.131.717,07 | -195,3% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.350 | 535,53 | -1.258.485,63 | -217,2% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -240 | 528,91 | -126.938,40 | -21,9% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -240 | 530,83 | -127.399,99 | -22,0% | |
| 2026-07-17 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -293 | 542,43 | -158.932,25 | -27,4% | |
| 2026-07-16 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -150 | 536,29 | -80.443,07 | -13,9% | |
| 2026-07-16 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -440 | 533,28 | -234.644,39 | -40,5% | |
| 2026-07-16 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -520 | 532,14 | -276.711,50 | -47,7% | |
| 2026-07-16 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -720 | 535,20 | -385.342,42 | -66,5% | |
| 2026-07-16 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.198 | 534,31 | -640.100,62 | -110,5% | |
| 2026-07-16 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.400 | 528,42 | -739.782,96 | -127,7% | |
| 2026-07-16 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.924 | 530,14 | -1.019.998,79 | -176,0% | |
| 2026-07-16 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -3.057 | 529,46 | -1.618.571,75 | -279,3% | |
| 2026-07-16 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -11 | 537,11 | -5.908,21 | -1,0% | |
| 2026-07-16 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -80 | 527,31 | -42.185,08 | -7,3% | |
| 2026-07-16 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -120 | 529,81 | -63.577,20 | -11,0% | |
| 2026-07-16 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -80 | 536,85 | -42.948,21 | -7,4% | |
| 2026-07-16 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -3.279 | 534,21 | -1.751.679,18 | -302,3% | |
| 2026-07-16 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -1.519 | 534,99 | -812.648,44 | -140,2% | |
| 2026-07-16 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -1.041 | 535,88 | -557.850,87 | -96,3% | |
| 2026-07-16 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -861 | 531,97 | -458.025,48 | -79,0% | |
| 2026-07-16 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -800 | 532,94 | -426.351,52 | -73,6% | |
| 2026-07-16 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -600 | 527,60 | -316.557,00 | -54,6% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -120 | 523,97 | -62.876,80 | -10,8% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -80 | 525,43 | -42.034,00 | -7,3% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -80 | 521,82 | -41.745,60 | -7,2% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -48 | 520,92 | -25.003,96 | -4,3% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -40 | 534,09 | -21.363,60 | -3,7% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -40 | 527,55 | -21.102,00 | -3,6% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -641 | 529,03 | -339.105,67 | -58,5% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -825 | 533,08 | -439.790,75 | -75,9% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.044 | 531,03 | -554.390,62 | -95,7% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -3.295 | 531,97 | -1.752.833,90 | -302,5% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -160 | 533,22 | -85.314,80 | -14,7% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -120 | 534,27 | -64.112,80 | -11,1% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -120 | 529,66 | -63.559,60 | -11,0% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -120 | 527,77 | -63.332,40 | -10,9% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -203 | 523,20 | -106.210,09 | -18,3% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -189 | 521,84 | -98.627,91 | -17,0% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -278 | 530,97 | -147.609,05 | -25,5% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -280 | 525,24 | -147.066,39 | -25,4% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -440 | 524,40 | -230.734,02 | -39,8% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -577 | 530,12 | -305.878,37 | -52,8% | |
| 2026-07-15 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -800 | 532,06 | -425.647,44 | -73,4% | |
| 2026-07-14 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -959 | 529,21 | -507.512,20 | -87,6% | |
| 2026-07-14 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.220 | 527,06 | -643.009,91 | -111,0% | |
| 2026-07-14 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -3.492 | 526,13 | -1.837.255,39 | -317,0% | |
| 2026-07-14 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.468 | 525,16 | -770.940,46 | -133,0% | |
| 2026-07-14 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -107 | 531,08 | -56.825,68 | -9,8% | |
| 2026-07-14 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -200 | 532,60 | -106.520,40 | -18,4% | |
| 2026-07-14 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -554 | 530,67 | -293.992,62 | -50,7% | |
| 2026-07-14 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -660 | 528,13 | -348.568,51 | -60,1% | |
| 2026-07-14 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -840 | 524,15 | -440.283,56 | -76,0% | |
| 2026-07-13 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -320 | 539,60 | -172.673,41 | -29,8% | |
| 2026-07-13 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -40 | 542,80 | -21.712,00 | -3,7% | |
| 2026-07-13 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -360 | 541,10 | -194.795,89 | -33,6% | |
| 2026-07-13 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -409 | 538,60 | -220.289,32 | -38,0% | |
| 2026-07-13 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -665 | 537,66 | -357.545,36 | -61,7% | |
| 2026-07-13 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.020 | 533,70 | -544.376,24 | -93,9% | |
| 2026-07-13 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.191 | 535,47 | -1.173.213,46 | -202,4% | |
| 2026-07-13 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.223 | 536,52 | -1.192.674,40 | -205,8% | |
| 2026-07-13 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.272 | 534,63 | -1.214.669,36 | -209,6% | |
| 2026-07-10 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.578 | 547,17 | -863.440,41 | -149,0% | |
| 2026-07-10 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -80 | 553,47 | -44.277,60 | -7,6% | |
| 2026-07-10 | MALCOLM JAN | Director | Open Market Sale | -325 | 550,59 | -178.941,75 | -30,9% | |
| 2026-07-10 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -364 | 544,54 | -198.211,90 | -34,2% | |
| 2026-07-10 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -400 | 548,44 | -219.375,20 | -37,9% | |
| 2026-07-10 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -600 | 540,37 | -324.222,66 | -55,9% | |
| 2026-07-10 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -676 | 543,34 | -367.296,49 | -63,4% | |
| 2026-07-10 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -970 | 541,47 | -525.225,80 | -90,6% | |
| 2026-07-10 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.438 | 546,42 | -785.750,23 | -135,6% | |
| 2026-07-10 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.524 | 545,54 | -831.408,75 | -143,5% | |
| 2026-07-10 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.870 | 542,49 | -1.014.450,69 | -175,1% | |
| 2026-07-09 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.536 | 549,01 | -843.272,60 | -145,5% | |
| 2026-07-09 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.863 | 551,03 | -1.577.610,63 | -272,2% | |
| 2026-07-09 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.648 | 552,38 | -910.323,23 | -157,1% | |
| 2026-07-09 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.452 | 550,12 | -798.779,76 | -137,8% | |
| 2026-07-09 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -801 | 553,29 | -443.185,05 | -76,5% | |
| 2026-07-09 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -640 | 554,23 | -354.704,13 | -61,2% | |
| 2026-07-09 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -440 | 548,16 | -241.189,08 | -41,6% | |
| 2026-07-09 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -120 | 555,76 | -66.691,60 | -11,5% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.710 | 553,42 | -946.350,42 | -163,3% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.490 | 552,51 | -823.241,09 | -142,1% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.118 | 554,45 | -619.880,13 | -107,0% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -925 | 551,56 | -510.190,13 | -88,0% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -923 | 549,52 | -507.210,01 | -87,5% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -785 | 550,45 | -432.100,66 | -74,6% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -702 | 557,82 | -391.590,62 | -67,6% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -291 | 555,75 | -161.723,57 | -27,9% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -379 | 556,64 | -210.966,90 | -36,4% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -637 | 548,62 | -349.471,70 | -60,3% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -320 | 560,79 | -179.453,60 | -31,0% | |
| 2026-07-08 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -220 | 558,78 | -122.932,66 | -21,2% | |
| 2026-07-07 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -200 | 553,12 | -110.623,22 | -19,1% | |
| 2026-07-07 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -241 | 554,36 | -133.599,77 | -23,1% | |
| 2026-07-07 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -505 | 560,49 | -283.047,80 | -48,8% | |
| 2026-07-07 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -596 | 555,50 | -331.078,89 | -57,1% | |
| 2026-07-07 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -726 | 556,55 | -404.058,20 | -69,7% | |
| 2026-07-07 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -800 | 562,60 | -450.076,80 | -77,7% | |
| 2026-07-07 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.096 | 557,78 | -611.323,59 | -105,5% | |
| 2026-07-07 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.875 | 558,90 | -1.047.938,06 | -180,8% | |
| 2026-07-07 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -3.399 | 559,76 | -1.902.628,66 | -328,3% | |
| 2026-07-07 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -62 | 563,24 | -34.920,76 | -6,0% | |
| 2026-07-06 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -329 | 550,78 | -181.205,14 | -31,3% | |
| 2026-07-06 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.098 | 546,93 | -1.147.467,74 | -198,0% | |
| 2026-07-06 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.116 | 549,87 | -1.163.514,76 | -200,8% | |
| 2026-07-06 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -131 | 551,88 | -72.296,88 | -12,5% | |
| 2026-07-06 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -3.354 | 549,03 | -1.841.458,69 | -317,8% | |
| 2026-07-06 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -135 | 553,39 | -74.707,35 | -12,9% | |
| 2026-07-06 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -306 | 553,90 | -169.494,81 | -29,2% | |
| 2026-07-06 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -1.031 | 548,00 | -564.988,00 | -97,5% | |
| 2026-07-02 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -225 | 556,36 | -125.180,75 | -21,6% | |
| 2026-07-02 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -258 | 548,73 | -141.572,70 | -24,4% | |
| 2026-07-02 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -299 | 554,45 | -165.779,17 | -28,6% | |
| 2026-07-02 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -384 | 550,02 | -211.209,02 | -36,4% | |
| 2026-07-02 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -658 | 548,00 | -360.584,79 | -62,2% | |
| 2026-07-02 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -990 | 555,83 | -550.267,44 | -95,0% | |
| 2026-07-02 | MAHON PAUL A | Officer, EVP & GENERAL COUNSEL | Open Market Sale | -1.467 | 551,30 | -808.751,38 | -139,6% | |
| 2026-07-02 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -40 | 558,37 | -22.334,80 | -3,9% | |
| 2026-07-02 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -2.942 | 555,67 | -1.634.790,26 | -282,1% | |
| 2026-07-02 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -118 | 549,77 | -64.872,32 | -11,2% | |
| 2026-07-02 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -130 | 548,75 | -71.337,62 | -12,3% | |
| 2026-07-02 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -192 | 548,01 | -105.217,25 | -18,2% | |
| 2026-07-02 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -320 | 557,63 | -178.440,42 | -30,8% | |
| 2026-07-02 | ROTHBLATT MARTINE A | Director, Officer, Chairperson & CEO | Open Market Sale | -640 | 551,59 | -353.019,20 | -60,9% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 5.399.649 | 0 | 5.399.649 | 3.201.883.611 | Neu | +100,0% | |
| Avoro Capital Advisors LLC | 3.010.000 | 0 | 3.010.000 | 1.569.833.400 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 2.264.247 | 0 | 2.264.247 | 1.342.653.186 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.957.539 | 0 | 1.957.539 | 1.160.781.476 | Neu | +100,0% | |
| STATE STREET CORP | 1.843.963 | 0 | 1.843.963 | 1.093.433.180 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 1.787.019 | 0 | 1.787.019 | 1.059.666.527 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.233.029 | 0 | 1.233.029 | 729.920.363 | Neu | +100,0% | |
| Caption Management, LLC | 1.151.645 | 0 | 1.151.645 | 682.902.452 | Neu | +100,0% | |
| Janus Henderson Group Ltd. | 866.930 | 0 | 866.930 | 514.015.988 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 862.496 | 0 | 862.496 | 511.442.878 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 826.226 | 0 | 826.226 | 486.424.477 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 697.843 | 0 | 697.843 | 413.806.942 | Neu | +100,0% | |
| ASSETMARK, INC | 616.050 | 0 | 616.050 | 365.305.135 | Neu | +100,0% | |
| FMR LLC | 528.346 | 0 | 528.346 | 313.298.624 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 512.739 | 0 | 512.739 | 304.029.148 | Neu | +100,0% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 457.000 | 0 | 457.000 | 270.991.860 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 436.566 | 0 | 436.566 | 258.874.907 | Neu | +100,0% | |
| BAILLIE GIFFORD & CO | 428.127 | 0 | 428.127 | 253.870.748 | Neu | +100,0% | |
| MORGAN STANLEY | 409.288 | 0 | 409.288 | 242.700.645 | Neu | +100,0% | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 343.659 | 0 | 343.659 | 203.782.914 | Neu | +100,0% | |
| Pictet Asset Management Holding SA | 309.220 | 0 | 309.220 | 183.306.233 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 304.772 | 0 | 304.772 | 180.723.701 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 300.481 | 0 | 300.481 | 178.179.223 | Neu | +100,0% | |
| Swedbank AB | 322.995 | 327.122 | -4.127 | 175.008.379 | Reduziert | -1,3% | |
| FULLER & THALER ASSET MANAGEMENT, INC. | 280.405 | 0 | 280.405 | 166.274.383 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 277.983 | 0 | 277.983 | 164.838.454 | Neu | +100,0% | |
| FIRST TRUST ADVISORS LP | 270.578 | 0 | 270.578 | 160.447.289 | Neu | +100,0% | |
| Eversept Partners, LP | 264.271 | 0 | 264.271 | 156.707.418 | Neu | +100,0% | |
| CITIGROUP INC | 255.620 | 0 | 255.620 | 151.577.548 | Neu | +100,0% | |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 252.702 | 0 | 252.702 | 149.847.285 | Neu | +100,0% | |
| IMC-Chicago, LLC | 243.062 | 0 | 243.062 | 144.130.905 | Neu | +100,0% | |
| Sofinnova Investments, Inc. | 240.370 | 0 | 240.370 | 142.534.603 | Neu | +100,0% | |
| UBS Group AG | 236.729 | 0 | 236.729 | 140.375.563 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 207.309 | 0 | 207.309 | 122.930.093 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 203.359 | 0 | 203.359 | 120.587.820 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 199.426 | 0 | 199.426 | 118.255.868 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 198.777 | 0 | 198.777 | 117.870.786 | Neu | +100,0% | |
| Nuveen, LLC | 190.697 | 0 | 190.697 | 113.079.508 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 187.187 | 0 | 187.187 | 110.998.147 | Neu | +100,0% | |
| Legal & General Group Plc | 186.794 | 0 | 186.794 | 110.765.107 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 220.634 | 0 | 220.634 | 107.503.917 | Neu | +100,0% | |
| Point72 Asset Management, L.P. | 170.703 | 0 | 170.703 | 101.223.465 | Neu | +100,0% | |
| FIFTH THIRD BANCORP | 164.978 | 0 | 164.978 | 97.828.539 | Neu | +100,0% | |
| Amundi | 147.599 | 0 | 147.599 | 87.523.256 | Neu | +100,0% | |
| Allspring Global Investments Holdings, LLC | 146.524 | 0 | 146.524 | 83.558.242 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 123.441 | 0 | 123.441 | 73.198.044 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 122.486 | 0 | 122.486 | 72.631.676 | Neu | +100,0% | |
| Epoch Investment Partners, Inc. | 120.682 | 0 | 120.682 | 71.562.013 | Neu | +100,0% | |
| Swiss National Bank | 120.055 | 0 | 120.055 | 71.190.214 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 119.106 | 0 | 119.106 | 70.627.476 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| Swedbank AB | 322.995 | 327.122 | -1,3% | 175.008.379 | 22,72 | 100 % | 16 Q |
| Robeco Institutional Asset Management B.V. | 123.056 | 127.902 | -3,8% | 66.675.431 | 8,66 | 76 % | 17 Q |
| Retirement Systems of Alabama | 89.496 | 98.378 | -9,0% | 48.491.618 | 6,30 | 100 % | 17 Q |
| Assenagon Asset Management S.A. | 84.538 | 47.183 | +79,2% | 45.805.225 | 5,95 | 100 % | 17 Q |
| ATWOOD & PALMER INC | 61.479 | 62.436 | -1,5% | 33.310.987 | 4,33 | 100 % | 17 Q |
| Polaris Capital Management, LLC | 53.450 | 96.650 | -44,7% | 28.960.814 | 3,76 | 100 % | 17 Q |
| Simplify Asset Management Inc. | 45.411 | 34.251 | +32,6% | 24.605.042 | 3,19 | 100 % | 7 Q |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | 39.450 | 40.530 | -2,7% | 21.375.193 | 2,78 | 100 % | 13 Q |
| Aware Super Pty Ltd as trustee of Aware Super | 34.202 | 72.530 | -52,8% | 18.531.670 | 2,41 | 100 % | 7 Q |
| ARDSLEY ADVISORY PARTNERS LP | 30.000 | 50.000 | -40,0% | 16.254.900 | 2,11 | 100 % | 3 Q |
| Erste Asset Management GmbH | 28.831 | 26.664 | +8,1% | 15.710.187 | 2,04 | 100 % | 17 Q |
| Nepsis Inc. | 27.273 | 42.194 | -35,4% | 14.777.330 | 1,92 | 0 % | 8 Q |
| Asset Management One Co., Ltd. | 22.742 | 23.722 | -4,1% | 12.322.298 | 1,60 | 100 % | 14 Q |
| Apollon Wealth Management, LLC | 22.585 | 13.288 | +70,0% | 12.237.231 | 1,59 | 37 % | 2 Q |
| ASR Vermogensbeheer N.V. | 19.047 | 1.221 | +1460,0% | 10.319.162 | 1,34 | 100 % | 6 Q |
| Resona Asset Management Co.,Ltd. | 15.391 | 16.725 | -8,0% | 8.344.892 | 1,08 | 100 % | 10 Q |
| Y-Intercept (Hong Kong) Ltd | 14.271 | 0 | +100,0% | 7.732.456 | 1,00 | 100 % | 7 Q |
| EVERGREEN CAPITAL MANAGEMENT LLC | 13.992 | 13.120 | +6,6% | 7.581.286 | 0,98 | 77 % | 9 Q |
| YOUSIF CAPITAL MANAGEMENT, LLC | 12.446 | 13.380 | -7,0% | 6.743.616 | 0,88 | 32 % | 17 Q |
| Louisiana State Employees Retirement System | 12.400 | 12.500 | -0,8% | 6.718.692 | 0,87 | 100 % | 17 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 227 | 1,6 | 783 |
| 31.03.2026 | ✓ | 845 | 44,7 | 24.884 |
| 31.12.2025 | ✓ | 824 | 46,0 | 21.204 |
| 30.09.2025 | ✓ | 705 | 41,9 | 16.559 |
| 30.06.2025 | ✓ | 660 | 44,2 | 11.877 |
| 31.03.2025 | ✓ | 659 | 45,9 | 13.022 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.957.539 | 1.160.781.476 |
| BOWEN HANES & CO INC | 85.000 | 50.403.300 |
| Logos Global Management LP | 80.000 | 47.438.400 |
| MARSHALL WACE, LLP | 75.977 | 45.052.842 |
| Vestal Point Capital, LP | 75.000 | 44.473.500 |
| Aware Super Pty Ltd as trustee of Aware Super | 72.530 | 43.008.839 |
| ARDSLEY ADVISORY PARTNERS LP | 50.000 | 29.649.000 |
| Tidal Investments LLC | 33.465 | 19.795.136 |
| Hudson Bay Capital Management LP | 20.918 | 12.403.956 |
| SEB Asset Management AB | 17.731 | 10.514.128 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| BlackRock, Inc. | 5.399.649 | 228.883 | +4.4 % | 3.201.883.611 |
| HRT FINANCIAL LP | 285.542 | 222.145 | +350.4 % | 169.319 |
| CITADEL ADVISORS LLC | 360.643 | 173.479 | +92.7 % | 213.854.086 |
| FIFTH THIRD BANCORP | 164.978 | 164.519 | +35842.9 % | 97.828.539 |
| Soleus Capital Management, L.P. | 187.187 | 127.187 | +212.0 % | 110.998.147 |
| FMR LLC | 528.346 | 124.516 | +30.8 % | 313.298.624 |
| BAILLIE GIFFORD & CO | 428.127 | 105.111 | +32.5 % | 253.870.748 |
| ACADIAN ASSET MANAGEMENT LLC | 300.204 | 99.673 | +49.7 % | 177.976 |
| FRANKLIN RESOURCES INC | 277.983 | 96.863 | +53.5 % | 164.838.454 |
| MILLENNIUM MANAGEMENT LLC | 153.372 | 89.299 | +139.4 % | 90.946.529 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| AQR CAPITAL MANAGEMENT LLC | 826.226 | -455.473 | -35.5 % | 486.424.477 |
| JANE STREET GROUP, LLC | 2.759 | -214.061 | -98.7 % | 1.636.032 |
| D. E. Shaw & Co., Inc. | 99.106 | -207.865 | -67.7 % | 58.767.876 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.264.247 | -177.245 | -7.3 % | 1.342.653.186 |
| VICTORY CAPITAL MANAGEMENT INC | 60.541 | -167.842 | -73.5 % | 35.899.602 |
| RENAISSANCE TECHNOLOGIES LLC | 1.787.019 | -122.240 | -6.4 % | 1.059.666.527 |
| Candriam S.C.A. | 63.066 | -64.149 | -50.4 % | 37.396.877 |
| Nuveen, LLC | 190.697 | -61.112 | -24.3 % | 113.079.508 |
| Tri Locum Partners LP | 70.370 | -50.551 | -41.8 % | 41.728.003 |
| SEIZERT CAPITAL PARTNERS, LLC | 104.667 | -40.855 | -28.1 % | 62.065.438 |
Zusätzlich aktuell von 266 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Δ-Balken |
|---|---|---|---|---|---|---|
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,19 % | 2.278.348 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -10,57 pp | |
| 10.02.2026 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G) | 5,70 % | 2.441.492 | +1,20 pp | |
| 12.05.2025 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 4,50 % | 2.026.416 | -1,00 pp | |
| 10.02.2025 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 5,50 % | 2.463.891 | -2,57 pp | |
| 05.02.2025 | STATE STREET CORPORATION | Passiv (13G) | 4,90 % | 2.199.994 | -0,10 pp | |
| 08.11.2024 | Martine A. Rothblatt | Passiv (13G/A) | 6,80 % | 3.194.162 | -1,00 pp | |
| 16.10.2024 | STATE STREET CORPORATION | Passiv (13G) | 5,00 % | 2.238.224 | Neu | |
| 10.06.2024 | The Vanguard Group | Passiv (13G/A) | 10,57 % | 4.687.393 | +0,62 pp | |
| 14.02.2024 | Martine A. Rothblatt | Passiv (13G/A) | 7,80 % | 3.900.308 | -0,20 pp | |
| 14.02.2024 | Avoro Capital Advisors LLC (+1) | Passiv (13G/A) | 6,10 % | 2.858.888 | -0,20 pp | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 9,95 % | 4.673.678 | +0,12 pp | |
| 13.02.2024 | RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734 (+1) | Passiv (13G/A) | 4,62 % | 2.170.214 | -0,52 pp | |
| 08.02.2024 | Wellington Management Company LLP | Passiv (13G/A) | 6,80 % | 3.195.591 | -1,69 pp | |
| 08.02.2024 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 8,07 % | 3.794.010 | -1,94 pp | |
| 24.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 11,30 % | 5.294.844 | +1,10 pp | |
| 10.07.2023 | Wellington Management Company LLP | Passiv (13G/A) | 8,49 % | 3.979.471 | Neu | |
| 10.07.2023 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 10,01 % | 4.688.824 | +4,37 pp | |
| 08.03.2023 | . BlackRock, Inc. | Passiv (13G/A) | 10,20 % | 4.726.986 | +0,30 pp | |
| 14.02.2023 | Avoro Capital Advisors LLC (+1) | Passiv (13G/A) | 6,30 % | 2.865.000 | -0,40 pp | |
| 13.02.2023 | RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734 (+1) | Passiv (13G/A) | 5,14 % | 2.344.492 | -1,34 pp | |
| 09.02.2023 | The Vanguard Group | Passiv (13G/A) | 9,83 % | 4.480.719 | +0,59 pp | |
| 06.02.2023 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G) | 5,64 % | 2.569.263 | Neu | |
| 02.02.2023 | Martine A. Rothblatt | Passiv (13G/A) | 8,00 % | 3.919.603 | -0,50 pp | |
| 24.01.2023 | . BlackRock, Inc. | Passiv (13G/A) | 9,90 % | 4.510.211 | +0,50 pp | |
| 11.02.2022 | RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734 (+1) | Passiv (13G/A) | 6,48 % | 2.917.191 | -1,64 pp | |
| 11.02.2022 | Avoro Capital Advisors LLC (+1) | Passiv (13G/A) | 6,70 % | 3.035.000 | +0,30 pp | |
| 10.02.2022 | The Vanguard Group | Passiv (13G/A) | 9,24 % | 4.160.963 | +0,32 pp | |
| 04.02.2022 | Martine A. Rothblatt | Passiv (13G/A) | 8,50 % | 4.118.487 | +0,90 pp | |
| 03.02.2022 | . BlackRock, Inc. | Passiv (13G/A) | 9,40 % | 4.239.175 | -0,20 pp |
US Congress Trades (STOCK Act)
| Datum | Mitglied | Partei | Kammer | Typ | Betrag-Bereich |
|---|---|---|---|---|---|
| 31.10.2025 | Lisa McClain | – | House | Verkauf | $1,001 – $15,000 |
| 30.10.2025 | Lisa McClain | – | House | Verkauf | $1,001 – $15,000 |
| 30.10.2025 | Lisa McClain | – | House | Kauf | $1,001 – $15,000 |
| 11.06.2025 | Lisa McClain | – | House | Kauf | $1,001 – $15,000 |
Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | – | 274.900.000 $ | 5,82 $ | 6.714.200.000 $ | 5.901.100.000 $ |
| 2025-12-31 | 10-K | – | 1.334.700.000 $ | 27,86 $ | 7.880.000.000 $ | 7.096.200.000 $ |
| 2025-09-30 | 10-Q | – | 338.700.000 $ | 7,16 $ | 7.351.100.000 $ | 6.590.200.000 $ |
| 2025-06-30 | 10-Q | – | 309.500.000 $ | 6,41 $ | 7.908.000.000 $ | 7.173.600.000 $ |
| 2025-03-31 | 10-Q | – | 322.200.000 $ | 6,63 $ | 7.743.900.000 $ | 6.807.200.000 $ |
| 2024-12-31 | 10-K | – | 1.195.100.000 $ | 24,64 $ | 7.364.000.000 $ | 6.444.000.000 $ |
| 2024-09-30 | 10-Q | – | 309.100.000 $ | 6,39 $ | 7.123.100.000 $ | 6.100.900.000 $ |
| 2024-06-30 | 10-Q | – | 278.100.000 $ | 5,85 $ | 6.723.200.000 $ | 5.697.200.000 $ |
| 2024-03-31 | 10-Q | – | 306.600.000 $ | 6,17 $ | 6.495.200.000 $ | 5.338.100.000 $ |
| 2023-12-31 | 10-K | – | 984.800.000 $ | 19,81 $ | 7.167.000.000 $ | 5.984.800.000 $ |
| 2023-09-30 | 10-Q | – | 267.600.000 $ | 5,38 $ | 7.023.600.000 $ | 5.712.100.000 $ |
| 2023-06-30 | 10-Q | – | 259.200.000 $ | 5,24 $ | 6.681.300.000 $ | 5.411.000.000 $ |
| 2023-03-31 | 10-Q | – | 240.900.000 $ | 4,86 $ | 6.346.000.000 $ | 5.123.200.000 $ |
| 2022-12-31 | 10-K | – | 727.300.000 $ | 15,00 $ | 6.044.500.000 $ | 4.796.700.000 $ |
| 2022-09-30 | 10-Q | – | 239.300.000 $ | 4,91 $ | 5.781.600.000 $ | 4.562.200.000 $ |
| 2022-06-30 | 10-Q | – | 116.000.000 $ | 2,41 $ | 5.543.300.000 $ | 4.318.400.000 $ |
| 2022-03-31 | 10-Q | – | 239.900.000 $ | 5,03 $ | 5.359.800.000 $ | 4.176.300.000 $ |
| 2021-12-31 | 10-K | – | 475.800.000 $ | 10,06 $ | 5.169.100.000 $ | 3.958.900.000 $ |
| 2021-09-30 | 10-Q | – | 162.700.000 $ | 3,42 $ | 5.048.900.000 $ | 3.829.700.000 $ |
| 2021-06-30 | 10-Q | – | 172.600.000 $ | 3,65 $ | 4.844.900.000 $ | 3.639.500.000 $ |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Tyvaso | 1,9 Mrd. | 1,6 Mrd. | 1,2 Mrd. | 873,0 Mio. | 607,5 Mio. | 59,0 % | +15,9% | |
| Tyvaso DPI | 1,3 Mrd. | 1,0 Mrd. | 731,1 Mio. | – | – | 40,6 % | +25,0% | |
| Nebulized Tyvaso | 585,7 Mio. | 586,8 Mio. | 502,6 Mio. | – | – | 18,4 % | -0,2% | |
| Remodulin | 526,8 Mio. | 538,1 Mio. | 494,8 Mio. | 500,2 Mio. | 513,7 Mio. | 16,6 % | -2,1% | |
| Orenitram | 496,9 Mio. | 434,3 Mio. | 359,4 Mio. | 325,1 Mio. | 306,1 Mio. | 15,6 % | +14,4% | |
| Unituxin | 226,8 Mio. | 238,7 Mio. | 198,9 Mio. | 182,9 Mio. | 202,3 Mio. | 7,1 % | -5,0% | |
| Adcirca | 30,0 Mio. | 23,8 Mio. | 28,9 Mio. | 41,3 Mio. | 55,9 Mio. | 0,9 % | +26,1% | |
| Product And Service Other | 24,0 Mio. | 22,1 Mio. | 11,8 Mio. | 13,8 Mio. | – | 0,8 % | +8,6% |
Quartalsverlauf
| Segment | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Tyvaso | 478,0 Mio. | 469,6 Mio. | 466,3 Mio. | 433,8 Mio. | 398,2 Mio. | 372,5 Mio. | 59,8 % | +10,2% | |
| Tyvaso DPI | 336,2 Mio. | 315,2 Mio. | 302,5 Mio. | 274,6 Mio. | 258,3 Mio. | 227,5 Mio. | 42,1 % | +22,4% | |
| Nebulized Tyvaso | 141,8 Mio. | 154,4 Mio. | 163,8 Mio. | 159,2 Mio. | 139,9 Mio. | 145,0 Mio. | 17,7 % | -10,9% | |
| Orenitram | 131,1 Mio. | 123,9 Mio. | 120,7 Mio. | 113,2 Mio. | 107,1 Mio. | 106,2 Mio. | 16,4 % | +15,8% | |
| Remodulin | 125,9 Mio. | 134,7 Mio. | 138,2 Mio. | 128,3 Mio. | 147,3 Mio. | 128,0 Mio. | 15,7 % | -1,9% | |
| Unituxin | 47,9 Mio. | 58,4 Mio. | 58,2 Mio. | 61,1 Mio. | 51,7 Mio. | 58,4 Mio. | 6,0 % | -21,6% | |
| Adcirca | 9,7 Mio. | 6,5 Mio. | 6,0 Mio. | 7,0 Mio. | 5,7 Mio. | 6,4 Mio. | 1,2 % | +38,6% | |
| Product And Service Other | 6,9 Mio. | 5,5 Mio. | 5,0 Mio. | 5,5 Mio. | 4,9 Mio. | 6,2 Mio. | 0,9 % | +25,5% |
Regionen
| Region | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| US | 3,0 Mrd. | 2,7 Mrd. | 2,2 Mrd. | 1,8 Mrd. | 1,6 Mrd. | 95,4 % | +10,9% | |
| Non Us | 145,7 Mio. | 137,7 Mio. | 125,3 Mio. | 122,2 Mio. | 121,3 Mio. | 4,6 % | +5,8% |
Quartalsverlauf
| Region | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|---|
| US | 774,8 Mio. | 759,8 Mio. | 749,6 Mio. | 717,3 Mio. | 675,2 Mio. | 641,5 Mio. | 96,9 % | +8,0% | |
| Non Us | 24,7 Mio. | 38,8 Mio. | 44,8 Mio. | 31,6 Mio. | 39,7 Mio. | 36,2 Mio. | 3,1 % | -21,8% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 06.05.2026 | 781,5 Mio. USD | 5,82 |
| Q3 2025 | 30.09.2025 | 29.10.2025 | 799,5 Mio. USD | 7,16 |
| Q2 2025 | 30.06.2025 | 30.07.2025 | 798,6 Mio. USD | 6,41 |
| Q1 2025 | 31.03.2025 | 30.04.2025 | 794,4 Mio. USD | 6,63 |
| Q3 2024 | 30.09.2024 | 30.10.2024 | 748,9 Mio. USD | 6,39 |
| Q2 2024 | 30.06.2024 | 31.07.2024 | 714,9 Mio. USD | 5,85 |
| Q1 2024 | 31.03.2024 | 01.05.2024 | 677,7 Mio. USD | 6,17 |
| Q3 2023 | 30.09.2023 | 01.11.2023 | 609,4 Mio. USD | 5,38 |
| Q2 2023 | 30.06.2023 | 02.08.2023 | 596,5 Mio. USD | 5,24 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 06.05.2026 | 10-Q | 31.03.2026 | 36 Tage | SEC » |
| 25.02.2026 | 10-K | 31.12.2025 | 56 Tage | SEC » |
| 29.10.2025 | 10-Q | 30.09.2025 | 29 Tage | SEC » |
| 30.07.2025 | 10-Q | 30.06.2025 | 30 Tage | SEC » |
| 30.04.2025 | 10-Q | 31.03.2025 | 30 Tage | SEC » |
| 26.02.2025 | 10-K | 31.12.2024 | 57 Tage | SEC » |
| 30.10.2024 | 10-Q | 30.09.2024 | 30 Tage | SEC » |
| 31.07.2024 | 10-Q | 30.06.2024 | 31 Tage | SEC » |
| 01.05.2024 | 10-Q | 31.03.2024 | 31 Tage | SEC » |
| 21.02.2024 | 10-K | 31.12.2023 | 52 Tage | SEC » |
| 01.11.2023 | 10-Q | 30.09.2023 | 32 Tage | SEC » |
| 02.08.2023 | 10-Q | 30.06.2023 | 33 Tage | SEC » |
| 03.05.2023 | 10-Q | 31.03.2023 | 33 Tage | SEC » |
| 22.02.2023 | 10-K | 31.12.2022 | 53 Tage | SEC » |
| 02.11.2022 | 10-Q | 30.09.2022 | 33 Tage | SEC » |
| 03.08.2022 | 10-Q | 30.06.2022 | 34 Tage | SEC » |
| 04.05.2022 | 10-Q | 31.03.2022 | 34 Tage | SEC » |
| 24.02.2022 | 10-K | 31.12.2021 | 55 Tage | SEC » |
| 03.11.2021 | 10-Q | 30.09.2021 | 34 Tage | SEC » |
| 04.08.2021 | 10-Q | 30.06.2021 | 35 Tage | SEC » |
| 05.05.2021 | 10-Q | 31.03.2021 | 35 Tage | SEC » |
| 24.02.2021 | 10-K | 31.12.2020 | 55 Tage | SEC » |
| 28.10.2020 | 10-Q | 30.09.2020 | 28 Tage | SEC » |
| 29.07.2020 | 10-Q | 30.06.2020 | 29 Tage | SEC » |
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | HV-Termin (US) | Stichtag (US) | Form | |
|---|---|---|---|---|---|
| 29.04.2026 | HV-Einladung | — | — | DEFA14A | SEC » |
| 29.04.2026 | HV-Einladung | 26.06.2026 Jahres-HV | 28.04.2026 | DEF 14A | SEC » |
| 29.04.2025 | HV-Einladung | — | — | DEFA14A | SEC » |
| 29.04.2025 | HV-Einladung | 26.06.2025 Jahres-HV | 28.04.2025 | DEF 14A | SEC » |
| 29.04.2024 | HV-Einladung | — | — | DEFA14A | SEC » |
| 29.04.2024 | HV-Einladung | 26.06.2024 Jahres-HV | 29.04.2024 | DEF 14A | SEC » |
| 28.04.2023 | HV-Einladung | — | — | DEFA14A | SEC » |
| 28.04.2023 | HV-Einladung | — | — | DEF 14A | SEC » |
| 29.04.2022 | HV-Einladung | — | — | DEFA14A | SEC » |
| 29.04.2022 | HV-Einladung | 27.06.2022 Jahres-HV | 28.04.2022 | DEF 14A | SEC » |
| 10.09.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
| 19.08.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
| 19.08.2021 | HV-Einladung | 30.09.2021 a.o. HV | 10.08.2021 | DEF 14A | SEC » |
| 04.08.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
| 14.07.2021 | Vorläufig | — | — | PRE 14A | SEC » |
| 17.06.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
| 29.04.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
| 29.04.2021 | HV-Einladung | 25.06.2021 Jahres-HV | 30.04.2021 | DEF 14A | SEC » |
| 29.04.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).
Übernahmen & Fusionen (M&A)
M&A-relevante SEC-Filings der letzten sechs Jahre: Übernahmeangebote (Tender Offers), Fusionen (425/S-4), Aktienrückkauf-Angebote (Self-Tender) und Going-Private-Transaktionen. Geführt nach dem einreichenden Emittenten.
| Datum (US) | Kategorie | Form | Deal-Konditionen | SEC |
|---|---|---|---|---|
| 13.12.2023 | Übernahmeangebot | SC TO-T/A | – | SEC » |
| 12.12.2023 | Übernahmeangebot | SC TO-T/A | – | SEC » |
| 04.12.2023 | Übernahmeangebot | SC TO-T/A | – | SEC » |
| 13.11.2023 | Übernahmeangebot | SC TO-T | $3,25 Cash | SEC » |
| 01.11.2023 | Übernahmeangebot | SC TO-C | – | SEC » |
| 30.10.2023 | Übernahmeangebot | SC TO-C | – | SEC » |
| 30.10.2023 | Übernahmeangebot | SC TO-C | – | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Deal-Konditionen aus dem Dokument extrahiert (Tender: SC TO-T/-I/SC 14D9; Fusion: 425/S-4 — Gegenpartei + Umtauschverhältnis), ohne Gewähr — Original siehe SEC-Link.
Kritische 8-K Meldungen ⓘ
HOCH Abgang Schlüsselpersonen (23.07.2026)
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 23.07.2026 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 22.01.2026 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of… |
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 23.07.2026 | Personalwechsel | 0,00 | 50 | United Therapeutics hat Victor Dzau, MD als neues Mitglied des Vorstands ernannt und ihm Anrechte unter dem Aktienincentivierungsplan verlie… 🔒 | SEC |
| 29.06.2026 | HV-Abstimmung | 0,00 | 40 | Die Aktionäre von United Therapeutics genehmigten am 26. Juni 2026 das neue Stock Incentive Plan 2026, das zur Verwaltung von Aktienvergütun… 🔒 | SEC |
| 06.05.2026 | Quartalszahlen | 0,00 | 40 | United Therapeutics veröffentlichte Geschäftsergebnisse für Q1 2026 (Quartal endend 31. März 2026). Konkrete Zahlen und deren Impact nicht a… 🔒 | SEC |
| 30.03.2026 | Sonstiges | 0,60 | 70 | United Therapeutics meldete positive Ergebnisse der TETON-1-Studie für Tyvaso® bei idiopathischer Lungenfibrose. Die Daten könnten zur Zulas… 🔒 | SEC |
| 09.03.2026 | Wesentliche Vereinbarung | 0,68 | 70 | United Therapeutics kündigte ein 2-Milliarden-Dollar-Aktienrückkaufprogramm an, das bis März 2027 läuft, zusammen mit zwei beschleunigten Rü… 🔒 | SEC |
| 02.03.2026 | Guidance-Update | 0,75 | 78 | United Therapeutics kündigte positive Ergebnisse der ADVANCE OUTCOMES-Studie von Ralinepag bei Patienten mit pulmonaler arterieller Hyperton… 🔒 | SEC |
| 25.02.2026 | Quartalszahlen | 0,00 | 50 | United Therapeutics veröffentlichte am 25. Februar 2026 Finanzzergebnisse und Business Updates für das Geschäftsjahr 2025. | SEC |
| 22.01.2026 | Personalwechsel | 0,00 | 15 | United Therapeutics erhöhte die Größe des Board of Directors auf 13 Mitglieder. Dies ist eine administrative Governance-Änderung ohne direkt… 🔒 | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-30 | 3.068 | 544,92 | 1.671.815 |
| 2026-06-18 | 844 | 551,47 | 465.441 |
| 2026-06-17 | 684 | 548,27 | 375.017 |
| 2026-06-16 | 8.926 | 549,57 | 4.905.462 |
| 2026-06-15 | 48 | 545,96 | 26.206 |
| 2026-06-08 | 987 | 549,87 | 542.722 |
| 2026-06-04 | 614 | 549,47 | 337.375 |
| 2026-05-28 | 2 | 570,75 | 1.142 |
| 2026-05-19 | 9.277 | 566,99 | 5.259.966 |
Hinweis
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet — Stand: 28.07.2026.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Signal-Komponenten und Gewichte.